Immunotherapy in frail non-small-cell lung cancer patients

被引：2
|
作者：
Gijtenbeek, Rolof G. P. [1 ]
Noordhof, Anneloes L. [1 ]
Asmara, Oke D. [1 ]
Groen, Harry J. M. [2 ,3 ]
van Geffen, Wouter H. [1 ]
机构：
[1] Med Ctr Leeuwarden, Dept Resp Med, NL-8934 AD Leeuwarden, Netherlands
[2] Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands
[3] Univ Groningen, Groningen, Netherlands
来源：
LANCET | 2024年 / 403卷 / 10440期
关键词：
D O I：
10.1016/S0140-6736(24)00792-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1986 / 1986
页数：1
相关论文
共 50 条
  • [21] Palliative immunotherapy in the frail elderly: non-small cell lung cancer
    Alexa, Teodora Stratulat
    Alexa, Ioana
    Antoniu, Sabina
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (02) : 191 - 193
  • [22] Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy
    Stenehjem, David
    Lubinga, Solomon
    Betts, Keith A.
    Tang, Wenxi
    Jenkins, Mads
    Yuan, Yong
    Hartman, John
    Rao, Sumati
    Lam, Jenny
    Waterhouse, David
    FUTURE ONCOLOGY, 2021, 17 (22) : 2940 - 2949
  • [23] TIME for biomarker-driven immunotherapy in non-small-cell lung cancer patients
    Karachaliou, Niki
    Rosell, Rafael
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (02) : 127 - 130
  • [24] Salvage Chemotherapy After Immunotherapy Failure in Non-Small-Cell Lung Cancer Patients
    Randon, G.
    Galli, G.
    De Toma, A.
    Pagani, F.
    Trevisan, B.
    Signorelli, D.
    Proto, C.
    Prelaj, A.
    Ferrara, R.
    Ganzinelli, M.
    Pallavicini, L.
    Di Mauro, R.
    Zilembo, N.
    De Braud, F.
    Garassino, M.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S416 - S416
  • [25] Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy?
    Krzyzanowska, Natalia
    Krawczyk, Pawel
    Wojas-Krawczyk, Kamila
    Kucharczyk, Tomasz
    Milanowski, Janusz
    CELLS, 2022, 11 (20)
  • [26] The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer
    Wu, Julie Tsu-Yu
    Corrigan, June
    Su, Chloe
    Dumontier, Clark
    La, Jennifer
    Khan, Aparjita
    Arya, Shipra
    Harris, Alex H. S.
    Backhus, Leah
    Das, Millie
    Do, Nhan V.
    Brophy, Mary T.
    Han, Summer S.
    Kelley, Michael
    Fillmore, Nathanael R.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (09)
  • [27] Immunotherapy for non-small-cell lung cancer: the past 10 years
    Vansteenkiste, Johan
    Craps, Julie
    De Brucker, Nele
    Wauters, Isabelle
    FUTURE ONCOLOGY, 2015, 11 (19) : 2681 - 2695
  • [28] Challenges of Immunotherapy in Stage IV Non-Small-Cell Lung Cancer
    Stock-Martineau, Sophie
    Magner, Kate
    Jao, Kevin
    Wheatley-Price, Paul
    JCO ONCOLOGY PRACTICE, 2021, 17 (08) : 465 - +
  • [29] First-Line Immunotherapy for Non-Small-Cell Lung Cancer
    Reck, Martin
    Remon, Jordi
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 586 - +
  • [30] Potential role of immunotherapy in advanced non-small-cell lung cancer
    de Mello, Ramon Andrade
    Veloso, Ana Flavia
    Catarina, Paulo Esrom
    Nadine, Sara
    Antoniou, Georgios
    ONCOTARGETS AND THERAPY, 2017, 10 : 21 - 30
12345